| 产品详情 |
| Edit |   |
|---|
| Product Name | NO-1886 |
|---|
| Description | Purity >98%. Lipoprotein lipase (LPL) mediates the hydrolysis of triglycerides in circulating very low density lipoproteins and chylomicrons. NO-1886 is an LPL activator that increases LPL mRNA and LPL activity in adipose tissue, myocardium, and skeletal muscle. This coincides with an elevation in post-heparin plasma LPL activity and LPL mass in rats. NO-1886 decreases plasma triglyceride concentration and increases plasma high-density lipoprotein cholesterol, resulting in inhibited development of atherosclerotic lesions in coronary arteries and aortas of rats and rabbits. |
|---|
| Size | n/a |
|---|
| Concentration | n/a |
|---|
| Applications | n/a |
|---|
| Other Names | [[4-[[(4-bromo-2-cyanophenyl)amino]carbonyl]phenyl]methyl]-phosphonic acid diethyl ester, Ibrolipim, Lipoprotein Lipase Activator, LPL Activator, OPF 009 |
|---|
| Gene, Accession, CAS # | CAS: 133208-93-2 |
|---|
| Catalog # | LS-H9030 |
|---|
| Price | |
|---|
| Order / More Info | NO-1886 from LIFESPAN BIOSCIENCES INC. |
|---|
| Product Specific References | n/a |
|---|
| 产品资料 |
|
|